Acer Therapeutics ACER

Quarterly report 2023-Q3
added 11-20-2023

Acer Therapeutics DIO Ratio 2011-2026 | ACER

Quarterly DIO Ratio Acer Therapeutics

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
5.34 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
5.34 K	5.34 K	5.34 K

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Axsome Therapeutics AXSM	168	$ 156.92	-1.23 %	$ 7.81 B	USA
	Kamada Ltd. KMDA	166	$ 8.5	-1.39 %	$ 260 M	Israel
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	BioMarin Pharmaceutical BMRN	644	$ 54.13	-1.64 %	$ 10.4 B	USA
	Coherus BioSciences CHRS	97.5	$ 1.52	-5.59 %	$ 178 M	USA
	Cellectis S.A. CLLS	23.3	$ 3.34	-4.02 %	$ 116 M	France
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA